The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Parkinson’s Disease Therapeutics Pipeline Program - Pre-Clinical, 2026Preclinical Efficacy Studies for CU-13001, a 15-Lipoxygenase Inhibitor for the Treatment of Parkinson’s Disease
Study Rationale:
For over 30 years, scientists have linked lipid oxidation, a type of damage to cellular fats, with Parkinson’s disease. However, the precise cause of this damage...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.